USPTO serial 79328925
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cheryl L. Burbach
Cheryl L. Burbach Erise IP, P.A.7015 College Blvd.Suite 700Overland Park, KS 66211| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software, recorded, for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable software and applications for mobile devices for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable computer software applications for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable computer software converters of natural language into machine executable commands; downloadable software development programmes; downloadable computer software development tools; downloadable software for computers for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable software for online messaging; downloadable software for operating and managing integrated circuit components; downloadable software for optical character recognition; downloadable software for processing digital images; downloadable software for processing images, graphics and text; downloadable software for processing images, graphics, audio, video and text; downloadable application software for cloud computing services; downloadable artificial intelligence software for analysis of blood and cells in humans; downloadable artificial intelligence software for healthcare for testing analysis of blood and cells in humans; downloadable authentication software for patient blood and cell testing and analysis; downloadable bioinformatics software for patient blood and cell testing and analysis; downloadable biometric software for patient blood and cell testing and analysis; downloadable computer interface software for patient blood and cell testing and analysis; downloadable computer programming software for patient blood and cell testing and analysis; downloadable computer programs for patient blood and cell testing and analysis; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; digital optical transmission apparatus; downloadable optical barcode recognition (OBR) software; downloadable optical character recognition (OCR) software; downloadable optical mark recognition (OMR) software; optical character recognition apparatus (OCR) | ACTIVE | — |
| 010 | Apparatus for blood analysis; apparatus for blood monitoring for medical use; apparatus for blood tests for medical use; apparatus for determining blood flow; apparatus for taking blood; apparatus for taking blood samples; autologous blood processing instruments, namely, syringes, needles and tourniquets; automated blood collection apparatus; automated blood collection instruments; automated blood separation apparatus; automated blood separation instruments; blood collection needles; blood collection tubes for medical use; blood filters | ACTIVE | — |
| 042 | Software as a service (SaaS) featuring computer software platforms for artificial intelligence; software as a service (SaaS) featuring software for deep learning; software as a service (SaaS) featuring software for deep neural networks; software as a service (SaaS) featuring software for machine learning; software as a service (SaaS) featuring software platforms for graphic design; software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks; computer software consultancy services; advisory services in the field of product development and quality improvement of software; advisory services relating to computer software design; advisory services relating to man-machine interfaces for computer software, namely, to the design and development of computers; advisory services relating to the rental of computers or computer software; advisory services relating to the use of computer software; software engineering; software engineering services; computer software installation; computer software maintenance services; research of computer software; computer software consultancy; computer software consultancy services; computer software consultation; computer software consulting; computer software development; computer software engineering; blood analysis services; blood analysis services for scientific research purposes; analysis of human serum for medical research | ACTIVE | — |
| 044 | Services for the medical testing of blood; medical analysis for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical analysis services relating to the treatment of persons provided by a medical laboratory; analysis of human serum for medical treatment; analysis of human tissues for medical treatment | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 16, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 28, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 8, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 8, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 2, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 2, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 2, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 14, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 9, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 17, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 28, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 30, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 23, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |